MedTrace Logo

Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease

NCT04891081 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-05-18

No results posted yet for this study

Summary

The aim of our study is to compare plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease and possible association with chronic hypoxic stress.

Conditions

  • Acyanotic Congenital Heart Disease
  • Cyanotic Congenital Heart Disease
  • Pheochromocytoma
  • Paraganglioma

Sponsors & Collaborators

  • University of Ljubljana, Faculty of Medicine

    collaborator OTHER

  • University Rehabilitation Institute, Republic of Slovenia

    collaborator OTHER

  • University Medical Centre Ljubljana

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2021-05-31
Completion
2021-06-09

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04891081 on ClinicalTrials.gov